raxibacumab Injectable Solution

Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Human Genome Sciences, Inc. (2014-04-02)
Oldest Current Product
2012-12-14
License(s)
BLA
RxNORM
INJECTABLE SOLUTION\RAXIBACUMAB
SPL Active
INTRAVENOUS\INJECTION\RAXIBACUMAB
SPL Moiety
INTRAVENOUS\INJECTION\RAXIBACUMAB

product(s) by strength(s)

raxibacumab 50 mg/ml injectable solution

original product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1494010104BLAHuman Genome Sciences, Inc.2012-12-14RAXIBACUMABINTRAVENOUSINJECTION125349a79c6f44-e978-44c3-b843-69793b03e830

application(s)

#idtitleapprovedtradenamesfda division
1125349raxibacumab Application2012-12-14raxibacumabCDER

spl(s)

#idtitlecategorytypelabelerlast updateversionproduct(s)
1a79c6f44-e978-44c3-b843-69793b03e830 (view SPL)These highlights do not include all the information needed to use RAXIBACUMAB safely and effectively. See full prescribing information for RAXIBACUMAB.RAXIBACUMAB injection, for intravenous use Initial U.S. Approval: 2012prescriptionHuman PrescriptionHuman Genome Sciences, Inc.2014-04-026494010104, 494010103

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII